NLRP3 and breast cancer: Further analysis of the CD11b+Gr1+-infiltrating cells demonstrated that depletion of NLRP3 in CAFs-attenuated recruitment of the monocytic fraction of CD11b+Gr1+ cells (CD11b+Ly6ChighLy6G−) into mammary tumours (Fig. 4g, h).